Specialties:
Ophthalmologist, Uveitis Specialist
Address:
17 East 102Nd Street, New York, NY 10029
Education:
Medical School - MD, Johns Hopkins University
Johns Hopkins Hospital (Residency - Internal Medicine)
Wilmer Eye Institute at Johns Hopkins (Residency - Ophthalmology)
New York Hospital Cornell University Med Ctr (Internship - Internal Medicine)
Johns Hopkins Hospital (Fellowship - Rheumatology)
Awards and Publications:
Jabs DA. AIDS and ophthalmology. Arch Ophthalmol 2008; 126: 1143-1146., Jabs DA, Prendergast RA, Campbell AL, Lee B, Akpek EK, Gerard HC. Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci 2007; 48: 5624-5629., Jabs DA, Martin BK, Ricks MO, Forman MS. for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. J Infect Dis 2006; 193: 1728-1737., The Standardization of Uveitis Nomenclature (SUN) Working Group . Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005; 140: 509-516., Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol 2005; 139: 900-905., Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL. for the Studies of Ocular Complications of AIDS Research Group. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 2005; 112: 771-779., Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK. for the Studies of Ocular Complications of AIDS Research Group. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology 2004; 111: 2224-2231., Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 2000; 130: 469-476., Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe JG, Louie JS, Nussenblatt RB, Stiehm RE, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000; 130: 492-513.
Board certifications:
American Board of Internal Medicine
About:
Douglas A. Jabs, M. D. , M. B. A. is Professor and Chairman of the Department of Ophthalmology at the Mount Sinai School of Medicine. He previously was the Alan C. Woods Professor of Ophthalmology a...